Clinical Trial Update: Cardiac GSI Feasibility Study [NA]

View source ↗

Summary

The document notes the completed status of a feasibility study evaluating a cardiac gamma-secretase inhibitor (GSI) in patients at high risk of significant coro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University Hospital Plymouth NHS Trust | Conditions: High Risk of Significant Coronary Artery Disease | NA | Status: COMPLETED